FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1728332092> ?p ?o ?g. }

• W1728332092 endingPage "160" @default.
• W1728332092 startingPage "156" @default.
• W1728332092 abstract "Based on a literature review and the SSG experience, the most important prognostic factors in high-grade osteosarcoma appear to be the presence of detectable metastases at diagnosis, tumour volume, old age, sex, histologic response, and possibly tumoral P-glycoprotein expression. However, for an adolescent patient with non-metastatic extremity disease, there is no consensus regarding prognostic factors at initial presentation, and currently there is thus no established method for dividing them into high- and low risk groups for the purpose of treatment differentiation. It should also be remembered that available prognostic factors have been identified only in a retrospective manner, following aggressive treatment of all patients. Thus patients in favourable prognostic groups may simply be patients who have had a good effect from aggressive treatment, and how they would have done with reduced treatment remains to be shown. Obviously the best method for prognostication would be the direct demonstration of micrometastatic disease in the lungs or in peripheral blood. In the relatively near future, this may become possible with immunoscintigrapy or immunohistochemistry utilizing monoclonal antibodies [29-31]. In Ewing's sarcoma, the most powerful factors indicating poor prognosis are metastases at diagnosis, poor histologic response, large tumour size and possibly pelvic localisation. There appears to be a somewhat better international consensus regarding prognostic factors in Ewing's sarcoma than in osteosarcoma. Although several studies have implemented intensified treatment for poor prognostic groups [8, 32], the role (if any) of high-dose treatment with stem cell rescue remains to be proven. The same factors are prognostic both for the development of metastases and local recurrence, but in addition, surgical treatment as opposed to radiotherapy appears to reduce local failure rate [12, 17, 33, 34]. As in osteosarcoma, the near future offers promise regarding the detection and quantification of micrometastatses and minimal residual disease, by means of PCR techniques recognizing specific genetic changes in the Ewing family of tumors [35]." @default.
• W1728332092 created "2016-06-24" @default.
• W1728332092 creator A5000823999 @default.
• W1728332092 creator A5003714110 @default.
• W1728332092 creator A5012797328 @default.
• W1728332092 creator A5036719499 @default.
• W1728332092 creator A5037256986 @default.
• W1728332092 creator A5060286246 @default.
• W1728332092 creator A5077846377 @default.
• W1728332092 creator A5084121308 @default.
• W1728332092 date "1997-01-01" @default.
• W1728332092 modified "2023-09-23" @default.
• W1728332092 title "Prognostic factors in bone sarcomas" @default.
• W1728332092 cites W1520897711 @default.
• W1728332092 cites W170676557 @default.
• W1728332092 cites W1810454109 @default.
• W1728332092 cites W1857092002 @default.
• W1728332092 cites W1902222293 @default.
• W1728332092 cites W1973224953 @default.
• W1728332092 cites W1979832482 @default.
• W1728332092 cites W1987139867 @default.
• W1728332092 cites W1999175195 @default.
• W1728332092 cites W2003557307 @default.
• W1728332092 cites W2013612727 @default.
• W1728332092 cites W2034648142 @default.
• W1728332092 cites W2045138137 @default.
• W1728332092 cites W2051183024 @default.
• W1728332092 cites W2056787996 @default.
• W1728332092 cites W2063718537 @default.
• W1728332092 cites W2063759313 @default.
• W1728332092 cites W2123303774 @default.
• W1728332092 cites W2123582134 @default.
• W1728332092 cites W2142136189 @default.
• W1728332092 cites W2198846739 @default.
• W1728332092 cites W2238767715 @default.
• W1728332092 cites W2329552021 @default.
• W1728332092 cites W2331701891 @default.
• W1728332092 cites W2409648288 @default.
• W1728332092 doi "https://doi.org/10.1080/17453674.1997.11744723" @default.
• W1728332092 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9057608" @default.
• W1728332092 hasPublicationYear "1997" @default.
• W1728332092 type Work @default.
• W1728332092 sameAs 1728332092 @default.
• W1728332092 citedByCount "57" @default.
• W1728332092 countsByYear W17283320922012 @default.
• W1728332092 countsByYear W17283320922013 @default.
• W1728332092 countsByYear W17283320922014 @default.
• W1728332092 countsByYear W17283320922015 @default.
• W1728332092 countsByYear W17283320922016 @default.
• W1728332092 countsByYear W17283320922017 @default.
• W1728332092 countsByYear W17283320922018 @default.
• W1728332092 countsByYear W17283320922019 @default.
• W1728332092 countsByYear W17283320922021 @default.
• W1728332092 countsByYear W17283320922022 @default.
• W1728332092 crossrefType "journal-article" @default.
• W1728332092 hasAuthorship W1728332092A5000823999 @default.
• W1728332092 hasAuthorship W1728332092A5003714110 @default.
• W1728332092 hasAuthorship W1728332092A5012797328 @default.
• W1728332092 hasAuthorship W1728332092A5036719499 @default.
• W1728332092 hasAuthorship W1728332092A5037256986 @default.
• W1728332092 hasAuthorship W1728332092A5060286246 @default.
• W1728332092 hasAuthorship W1728332092A5077846377 @default.
• W1728332092 hasAuthorship W1728332092A5084121308 @default.
• W1728332092 hasConcept C126322002 @default.
• W1728332092 hasConcept C142724271 @default.
• W1728332092 hasConcept C143998085 @default.
• W1728332092 hasConcept C167135981 @default.
• W1728332092 hasConcept C204232928 @default.
• W1728332092 hasConcept C2777586341 @default.
• W1728332092 hasConcept C2777760704 @default.
• W1728332092 hasConcept C2778256501 @default.
• W1728332092 hasConcept C2779134260 @default.
• W1728332092 hasConcept C71924100 @default.
• W1728332092 hasConceptScore W1728332092C126322002 @default.
• W1728332092 hasConceptScore W1728332092C142724271 @default.
• W1728332092 hasConceptScore W1728332092C143998085 @default.
• W1728332092 hasConceptScore W1728332092C167135981 @default.
• W1728332092 hasConceptScore W1728332092C204232928 @default.
• W1728332092 hasConceptScore W1728332092C2777586341 @default.
• W1728332092 hasConceptScore W1728332092C2777760704 @default.
• W1728332092 hasConceptScore W1728332092C2778256501 @default.
• W1728332092 hasConceptScore W1728332092C2779134260 @default.
• W1728332092 hasConceptScore W1728332092C71924100 @default.
• W1728332092 hasIssue "sup273" @default.
• W1728332092 hasLocation W17283320921 @default.
• W1728332092 hasLocation W17283320922 @default.
• W1728332092 hasOpenAccess W1728332092 @default.
• W1728332092 hasPrimaryLocation W17283320921 @default.
• W1728332092 hasRelatedWork W1630209420 @default.
• W1728332092 hasRelatedWork W1837577948 @default.
• W1728332092 hasRelatedWork W2094855561 @default.
• W1728332092 hasRelatedWork W2414589069 @default.
• W1728332092 hasRelatedWork W2424995763 @default.
• W1728332092 hasRelatedWork W2431198747 @default.
• W1728332092 hasRelatedWork W2467559786 @default.
• W1728332092 hasRelatedWork W2559608634 @default.
• W1728332092 hasRelatedWork W4246679218 @default.
• W1728332092 hasRelatedWork W4377090027 @default.

• next